\-\ Texto\\:\\ \ \(0\)\
\-\ fetal\\ growth\\ parameters\\ corresponded\\ with\\ period\\ of\\ gestation\\ and\\ amniotic\\ fluid\\ was\\ adequate\\.\ \(0\)\
\-\ the\\ placenta\\ was\\ on\\ the\\ posterior\\ uterine\\ wall\\ and\\ showed\\ a\\ well\\-marginated\\,\\ hypoechoic\\ mass\\ measuring\\ 6\\ x\\ 6\\.4cm\\(fig\\.\\ 1\\)\\.\\ color\\ doppler\\ showed\\ increased\\ vascularity\\ of\\ the\\ mass\\,\\ in\\ the\\ central\\ and\\ peripheral\\ portions\\ \\(fig\\.\\ 2\\)\\.\\ only\\ arterial\\ flow\\ was\\ detected\\ \\(fig\\.\\ 3\\)\\.\\ umbilical\\ and\\ uterine\\ artery\\ flow\\ indices\\ were\\ normal\\.\\ follow\\-up\\ scan\\ after\\ four\\ weeks\\ showed\\ an\\ increase\\ in\\ the\\ size\\ of\\ the\\ mass\\,\\ which\\ now\\ measured\\ 9\\ x\\ 8\\ cm\\.\\ the\\ amniotic\\ fluid\\ was\\ slightly\\ increased\\ in\\ volume\\,\\ with\\ mild\\ iugr\\ and\\ mild\\ pericardial\\ effusion\\ \\(fig\\ 4\\)\\.\\ the\\ patient\\ went\\ into\\ premature\\ labor\\ at\\ 35\\ weeks\\ and\\ delivered\\ a\\ male\\ baby\\ weighing\\ 2\\.1\\ kg\\ by\\ cesarian\\ section\\.\\ \ \(0\)\
\-\ histopathological\\ examination\\ of\\ the\\ placenta\\ proved\\ the\\ mass\\ to\\ be\\ a\\ chorioangioma\\.\ \(0\)\
\-\ the\\ patient\\ went\\ into\\ premature\\ labor\\ at\\ 35\\ weeks\\ and\\ delivered\\ a\\ male\\ baby\\ weighing\\ 2\\.1\\ kg\\ by\\ cesarian\\ section\\.\ \(0\)\
\-\ \\ histopathological\\ examination\\ of\\ the\\ placenta\\ proved\\ the\\ mass\\ to\\ be\\ a\\ chorioangioma\\.\ \(0\)\
\-\ huge\\ hypoechoic\\ placental\\ mass\\ developped\\ at\\ the\\ fetal\\ surface\\ of\\ the\\ placental\\ disk\\ and\\ displaying\\ central\\ and\\ peripheral\\ vessels\\ \\ with\\ arterial\\ flow\\ characteristics\\.\ \(0\)\
\-\ giant\\ placental\\ chorioangioma\\ highly\\ suspected\\ by\\ color\\ doppler\\ study\\ and\\ confirmed\\ by\\ histopatholoic\\ examination\ \(0\)\
\-\ if\\ color\\ doppler\\ study\\ shows\\ vascularity\\ within\\ the\\ tumor\\ the\\ \\ differential\\ diagnosis\\ is\\ only\\ with\\ the\\ exceptional\\ arteriovenous\\ anastomosis\\.\ \(0\)\
\-\ if\\ \\ no\\ intratumoral\\ vascularity\\ \\ depicted\\ the\\ differential\\ diagnosis\\ is\\ with\\ \\:\ \(0\)\
\-\ \\ \\ \\-intrachorionic\\ \\ hematoma\ \(1\)\
\-\ \\ \\ \\-trophoblastic\\ cyst\ \(1\)\
\-\ \\ \\ \\-subamniotic\\ hematoma\ \(1\)\
\-\ \\ \\ \\-hydatiform\\ mole\ \(1\)\
\-\ a\\ twenty\\-six\\-years\\ old\\ female\\ third\\ gravida\\ \\ with\\ history\\ of\\ two\\ prior\\ caesarean\\ sections\\ was\\ referred\\ for\\ routine\\ antenatal\\ ultrasound\\ scan\\ at\\ 20\\ weeks\\ of\\ gestation\ \(0\)\
\-\ chorioangioma\\ is\\ a\\ primary\\ benign\\ tumor\\ with\\ predominantly\\ vascular\\ involvement\\.\\ it\\ is\\ found\\ in\\ 1\\%\\ of\\ all\\ placentas\\ undergoing\\ careful\\ and\\ systematic\\ histopathological\\ examination\\.\\ the\\ preferred\\ localisation\\ is\\ on\\ the\\ fetal\\ side\\ of\\ the\\ placental\\ disk\\ and\\ it\\ may\\ protrude\\ into\\ the\\ amniochorial\\ cavity\\;\\ the\\ volume\\ is\\ variable\\ \\(but\\ rarely\\ exceeds\\ a\\ maximum\\ diameter\\ of\\ 4\\-5\\ cm\\)\\.\\ \ \(0\)\
\-\ a\\ rarer\\ form\\ is\\ the\\ clinically\\ relevant\\ large\\ chorioangioma\\ which\\ is\\ likely\\ to\\ be\\ associated\\ with\\ complications\\ like\\ polyhydramnios\\,\\ pre\\-term\\ birth\\,\\ iugr\\,\\ anemia\\,\\ fetal\\ congested\\ heart\\ decompensation\\,\\ non\\-immune\\ fetal\\ hydrops\\,\\ perinatal\\ mortality\\.\\ \ \(0\)\
\-\ hydrops\\ fetalis\\ due\\ to\\ a\\ large\\ chorioangioma\\ is\\ a\\ rare\\ complication\\.\\ our\\ patient\\'s\\ fetus\\ had\\ only\\ pericardial\\ effusion\\ without\\ prominent\\ signs\\ of\\ fetal\\ hydrops\\.\\ \ \(0\)\
\-\ there\\ are\\ only\\ few\\ reports\\ of\\ color\\ and\\ pulse\\ doppler\\ assessment\\ of\\ placental\\ chorioangioma\\.\\ while\\ grundy\\ et\\ al\\ \\[1\\]\\ and\\ hirata\\ et\\ al\\ \\[2\\]\\ found\\ only\\ arterial\\ blood\\ flow\\ in\\ the\\ chorioangioma\\,\\ kung\\ et\\ al\\ \\[3\\]\\ did\\ not\\ find\\ any\\ vascularity\\ in\\ one\\ patient\\ and\\ only\\ peripheral\\ venous\\ flow\\ in\\ the\\ second\\.\\ our\\ study\\ showed\\ both\\ central\\ and\\ peripheral\\ flow\\ with\\ only\\ arterial\\ characteristics\\.\\ in\\ patients\\ with\\ fetal\\ and\\/or\\ maternal\\ complications\\,\\ color\\ doppler\\ may\\ play\\ a\\ role\\ in\\ demonstrating\\ the\\ blood\\ flow\\ inside\\ the\\ mass\\.\\ as\\ for\\ those\\ without\\ complications\\ and\\ with\\ little\\ or\\ no\\ blood\\ flow\\,\\ it\\ is\\ of\\ limited\\ use\\.\\ \ \(0\)\
\-\ with\\ the\\ increasing\\ use\\ of\\ ultrasound\\,\\ prenatal\\ diagnosis\\ of\\ these\\ tumors\\ is\\ becoming\\ more\\ common\\(4\\)\\.\ \(0\)\
\-\ management\\ includes\\ umblical\\ blood\\ sampling\\ and\\ intravascular\\ transfusion\\ for\\ fetal\\ anemia\\ which\\ temporarily\\ corrects\\ the\\ hydrops\\ and\\ significantly\\ prolongs\\ the\\ pregnancy\\(5\\)\\.\\ ablation\\ of\\ the\\ blood\\ supply\\ of\\ plancental\\ chorioangioma\\ via\\ operative\\ fetoscopy\\ is\\ another\\ management\\ alternative\\ in\\ patients\\ with\\ large\\ chorioangioma\\(5\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chorioangioma\\:\\ 0\\.4680970369649605\ \(0\)\
\-\ fetal\\:\\ 0\\.23518227317899965\ \(0\)\
\-\ placental\\:\\ 0\\.20860694626406323\ \(0\)\
\-\ the\\:\\ 0\\.2085852429648365\ \(0\)\
\-\ hydrops\\:\\ 0\\.16922589470087934\ \(0\)\
\-\ flow\\:\\ 0\\.16879445997714765\ \(0\)\
\-\ color\\:\\ 0\\.1427951627044237\ \(0\)\
\-\ doppler\\:\\ 0\\.1417761188106478\ \(0\)\
\-\ fig\\:\\ 0\\.13905835463818472\ \(0\)\
\-\ only\\:\\ 0\\.13853116782491381\ \(0\)\
\-\ histopathological\\:\\ 0\\.13367426605757385\ \(0\)\
\-\ and\\:\\ 0\\.13091443685191712\ \(0\)\
\-\ vascularity\\:\\ 0\\.12671864686943468\ \(0\)\
\-\ placenta\\:\\ 0\\.11840932272652362\ \(0\)\
\-\ of\\:\\ 0\\.11778296180356809\ \(0\)\
\-\ arterial\\:\\ 0\\.10434783026764624\ \(0\)\
\-\ is\\:\\ 0\\.10410045621348549\ \(0\)\
\-\ cesarian\\:\\ 0\\.09681449994064045\ \(0\)\
\-\ blood\\:\\ 0\\.09198477174600467\ \(0\)\
\-\ iugr\\:\\ 0\\.09114110107454985\ \(0\)\
\-\ peripheral\\:\\ 0\\.09060755447698252\ \(0\)\
\-\ mass\\:\\ 0\\.08469912411294253\ \(0\)\
\-\ showed\\:\\ 0\\.08439722998857382\ \(0\)\
\-\ examination\\:\\ 0\\.08108175239419331\ \(0\)\
\-\ with\\:\\ 0\\.08063649380196497\ \(0\)\
\-\ in\\:\\ 0\\.0788027890990587\ \(0\)\
\-\ labor\\:\\ 0\\.07691462478151512\ \(0\)\
\-\ weighing\\:\\ 0\\.07631413628294291\ \(0\)\
\-\ weeks\\:\\ 0\\.07593925864256806\ \(0\)\
\-\ amniotic\\:\\ 0\\.07574445593670075\ \(0\)\
\-\ al\\:\\ 0\\.07550855848141162\ \(0\)\
\-\ et\\:\\ 0\\.07444395323995055\ \(0\)\
\-\ proved\\:\\ 0\\.07283055136480628\ \(0\)\
\-\ complications\\:\\ 0\\.07278417013480562\ \(0\)\
\-\ delivered\\:\\ 0\\.07124122591542452\ \(0\)\
\-\ kg\\:\\ 0\\.06673799589414829\ \(0\)\
\-\ central\\:\\ 0\\.06346125220839305\ \(0\)\
\-\ study\\:\\ 0\\.06337938719014322\ \(0\)\
\-\ gestation\\:\\ 0\\.0628261171172939\ \(0\)\
\-\ premature\\:\\ 0\\.06248435686630918\ \(0\)\
\-\ disk\\:\\ 0\\.06231734121083087\ \(0\)\
\-\ pericardial\\:\\ 0\\.061990660842398244\ \(0\)\
\-\ went\\:\\ 0\\.06151797964366601\ \(0\)\
\-\ uterine\\:\\ 0\\.05916376770889337\ \(0\)\
\-\ anemia\\:\\ 0\\.058207794544897065\ \(0\)\
\-\ characteristics\\:\\ 0\\.058093882451001694\ \(0\)\
\-\ section\\:\\ 0\\.05775899280450046\ \(0\)\
\-\ baby\\:\\ 0\\.057118065081769476\ \(0\)\
\-\ our\\:\\ 0\\.05612576875332929\ \(0\)\
\-\ volume\\:\\ 0\\.05566100086579278\ \(0\)\
\-\ was\\:\\ 0\\.055199226425349794\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.054132532181243254\ \(0\)\
\-\ by\\:\\ 0\\.05380803912971342\ \(0\)\
\-\ 35\\:\\ 0\\.05079947100478141\ \(0\)\
\-\ developped\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ histopatholoic\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ placentas\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ localisation\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ amniochorial\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ grundy\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ hirata\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ kung\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ prolongs\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ plancental\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ fetoscopy\\:\\ 0\\.05065886498095833\ \(0\)\
\-\ into\\:\\ 0\\.05051728828610122\ \(0\)\
\-\ diagnosis\\:\\ 0\\.049263830442258155\ \(0\)\
\-\ it\\:\\ 0\\.04864546882197512\ \(0\)\
\-\ use\\:\\ 0\\.0484750108472254\ \(0\)\
\-\ umblical\\:\\ 0\\.048407249970320226\ \(0\)\
\-\ at\\:\\ 0\\.04785963692152228\ \(0\)\
\-\ large\\:\\ 0\\.04761566741777141\ \(0\)\
\-\ effusion\\:\\ 0\\.047045721766181374\ \(0\)\
\-\ exceptional\\:\\ 0\\.046809703696496056\ \(0\)\
\-\ fetalis\\:\\ 0\\.046809703696496056\ \(0\)\
\-\ corrects\\:\\ 0\\.046809703696496056\ \(0\)\
\-\ management\\:\\ 0\\.046797062160374756\ \(0\)\
\-\ displaying\\:\\ 0\\.04557055053727493\ \(0\)\
\-\ gravida\\:\\ 0\\.04557055053727493\ \(0\)\
\-\ rarer\\:\\ 0\\.04455808868585795\ \(0\)\
\-\ decompensation\\:\\ 0\\.04455808868585795\ \(0\)\
\-\ hematoma\\:\\ 0\\.0443433727676959\ \(0\)\
\-\ indices\\:\\ 0\\.04370206438769187\ \(0\)\
\-\ intratumoral\\:\\ 0\\.04370206438769187\ \(0\)\
\-\ caesarean\\:\\ 0\\.04370206438769187\ \(0\)\
\-\ protrude\\:\\ 0\\.04370206438769187\ \(0\)\
\-\ perinatal\\:\\ 0\\.04370206438769187\ \(0\)\
\-\ temporarily\\:\\ 0\\.04370206438769187\ \(0\)\
\-\ which\\:\\ 0\\.043211921547117865\ \(0\)\
\-\ corresponded\\:\\ 0\\.04296054241203378\ \(0\)\
\-\ polyhydramnios\\:\\ 0\\.04296054241203378\ \(0\)\
\-\ exceeds\\:\\ 0\\.042306473675219836\ \(0\)\
\-\ congested\\:\\ 0\\.042306473675219836\ \(0\)\
\-\ depicted\\:\\ 0\\.04172138925281265\ \(0\)\
\-\ patient\\:\\ 0\\.041212114246123865\ \(0\)\
\-\ mole\\:\\ 0\\.04119211601271726\ \(0\)\
\-\ antenatal\\:\\ 0\\.04119211601271726\ \(0\)\
\-\ systematic\\:\\ 0\\.04119211601271726\ \(0\)\
\-\ differential\\:\\ 0\\.041164721868932365\ \(0\)\
\-\ found\\:\\ 0\\.040993286662343864\ \(0\)\
\-\ parameters\\:\\ 0\\.04026443696686542\ \(0\)\
\-\ relevant\\:\\ 0\\.04026443696686542\ \(0\)\
\-\ sampling\\:\\ 0\\.04026443696686542\ \(0\)\
\-\ huge\\:\\ 0\\.039469774242174537\ \(0\)\
\-\ ultrasound\\:\\ 0\\.03907826708465181\ \(0\)\
\-\ be\\:\\ 0\\.03855061687372947\ \(0\)\
\-\ play\\:\\ 0\\.03845731239075756\ \(0\)\
\-\ becoming\\:\\ 0\\.03845731239075756\ \(0\)\
\-\ anastomosis\\:\\ 0\\.03760128809259148\ \(0\)\
\-\ inside\\:\\ 0\\.03760128809259148\ \(0\)\
\-\ alternative\\:\\ 0\\.03760128809259148\ \(0\)\
\-\ scan\\:\\ 0\\.03758755566199669\ \(0\)\
\-\ intravascular\\:\\ 0\\.03734295472825498\ \(0\)\
\-\ transfusion\\:\\ 0\\.03734295472825498\ \(0\)\
\-\ sections\\:\\ 0\\.03685976611693339\ \(0\)\
\-\ if\\:\\ 0\\.0368105723651338\ \(0\)\
\-\ fluid\\:\\ 0\\.036579525927338215\ \(0\)\
\-\ cm\\:\\ 0\\.03638524111661276\ \(0\)\
\-\ find\\:\\ 0\\.03620569738011945\ \(0\)\
\-\ mild\\:\\ 0\\.03591389746612004\ \(0\)\
\-\ umbilical\\:\\ 0\\.03580887389832203\ \(0\)\
\-\ patients\\:\\ 0\\.03564040352031942\ \(0\)\
\-\ careful\\:\\ 0\\.03509133971761687\ \(0\)\
\-\ maternal\\:\\ 0\\.03460815110629528\ \(0\)\
\-\ ablation\\:\\ 0\\.03460815110629528\ \(0\)\
\-\ increased\\:\\ 0\\.03425913219983574\ \(0\)\
\-\ preferred\\:\\ 0\\.0336214580523791\ \(0\)\
\-\ maximum\\:\\ 0\\.0336214580523791\ \(0\)\
\-\ without\\:\\ 0\\.03341714719360227\ \(0\)\
\-\ role\\:\\ 0\\.03324694543183723\ \(0\)\
\-\ tumor\\:\\ 0\\.03313810943489917\ \(0\)\
\-\ fetus\\:\\ 0\\.03312751790643727\ \(0\)\
\-\ may\\:\\ 0\\.03188201109533654\ \(0\)\
\-\ supply\\:\\ 0\\.0318647843895059\ \(0\)\
\-\ to\\:\\ 0\\.031677029915261015\ \(0\)\
\-\ measured\\:\\ 0\\.03124217843315459\ \(0\)\
\-\ prenatal\\:\\ 0\\.03124217843315459\ \(0\)\
\-\ mortality\\:\\ 0\\.031158670605415436\ \(0\)\
\-\ little\\:\\ 0\\.031158670605415436\ \(0\)\
\-\ assessment\\:\\ 0\\.030995330421199122\ \(0\)\
\-\ adequate\\:\\ 0\\.030836657743789783\ \(0\)\
\-\ variable\\:\\ 0\\.030758989821833005\ \(0\)\
\-\ detected\\:\\ 0\\.030386154134988515\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.030386154134988515\ \(0\)\
\-\ portions\\:\\ 0\\.030104921085019058\ \(0\)\
\-\ pulse\\:\\ 0\\.029902965523666926\ \(0\)\
\-\ significantly\\:\\ 0\\.029772296767916824\ \(0\)\
\-\ for\\:\\ 0\\.02880342028306254\ \(0\)\
\-\ undergoing\\:\\ 0\\.028770607307650364\ \(0\)\
\-\ complication\\:\\ 0\\.028770607307650364\ \(0\)\
\-\ highly\\:\\ 0\\.02835522376212956\ \(0\)\
\-\ birth\\:\\ 0\\.02830541924984276\ \(0\)\
\-\ giant\\:\\ 0\\.028256057450187968\ \(0\)\
\-\ rarely\\:\\ 0\\.028256057450187968\ \(0\)\
\-\ male\\:\\ 0\\.028207886193673908\ \(0\)\
\-\ predominantly\\:\\ 0\\.02774020306292904\ \(0\)\
\-\ period\\:\\ 0\\.027695599080983548\ \(0\)\
\-\ form\\:\\ 0\\.027695599080983548\ \(0\)\
\-\ those\\:\\ 0\\.027106073901924935\ \(0\)\
\-\ few\\:\\ 0\\.026871398170176346\ \(0\)\
\-\ operative\\:\\ 0\\.02657316995500085\ \(0\)\
\-\ surface\\:\\ 0\\.02642985449395174\ \(0\)\
\-\ clinically\\:\\ 0\\.02632474411496354\ \(0\)\
\-\ cavity\\:\\ 0\\.026153863989471185\ \(0\)\
\-\ growth\\:\\ 0\\.02612031001489734\ \(0\)\
\-\ demonstrating\\:\\ 0\\.02612031001489734\ \(0\)\
\-\ suspected\\:\\ 0\\.025955515551270677\ \(0\)\
\-\ pregnancy\\:\\ 0\\.025923135483454547\ \(0\)\
\-\ another\\:\\ 0\\.025923135483454547\ \(0\)\
\-\ via\\:\\ 0\\.025890943127230934\ \(0\)\
\-\ four\\:\\ 0\\.025670675378149592\ \(0\)\
\-\ diameter\\:\\ 0\\.025458812292498273\ \(0\)\
\-\ increase\\:\\ 0\\.02542919533751272\ \(0\)\
\-\ limited\\:\\ 0\\.02528343458362515\ \(0\)\
\-\ prominent\\:\\ 0\\.024948468781605733\ \(0\)\
\-\ increasing\\:\\ 0\\.024948468781605733\ \(0\)\
\-\ slightly\\:\\ 0\\.024709871256422464\ \(0\)\
\-\ reports\\:\\ 0\\.024632563754124853\ \(0\)\
\-\ includes\\:\\ 0\\.024632563754124853\ \(0\)\
\-\ vessels\\:\\ 0\\.02458161692066547\ \(0\)\
\-\ routine\\:\\ 0\\.024531133246646433\ \(0\)\
\-\ measuring\\:\\ 0\\.02450606247766729\ \(0\)\
\-\ third\\:\\ 0\\.024119599383010608\ \(0\)\
\-\ rare\\:\\ 0\\.02391347884291626\ \(0\)\
\-\ second\\:\\ 0\\.0237147359897224\ \(0\)\
\-\ like\\:\\ 0\\.023543855864230037\ \(0\)\
\-\ referred\\:\\ 0\\.023439665830473234\ \(0\)\
\-\ confirmed\\:\\ 0\\.023357698794036288\ \(0\)\
\-\ tumors\\:\\ 0\\.023297007852274565\ \(0\)\
\-\ involvement\\:\\ 0\\.022927308661360214\ \(0\)\
\-\ did\\:\\ 0\\.02272400867053857\ \(0\)\
\-\ venous\\:\\ 0\\.0226161768183782\ \(0\)\
\-\ signs\\:\\ 0\\.022138924248131384\ \(0\)\
\-\ or\\:\\ 0\\.02203992248064822\ \(0\)\
\-\ heart\\:\\ 0\\.022025755378840675\ \(0\)\
\-\ side\\:\\ 0\\.02188356128552213\ \(0\)\
\-\ benign\\:\\ 0\\.02176015252021212\ \(0\)\
\-\ now\\:\\ 0\\.02174491748762017\ \(0\)\
\-\ size\\:\\ 0\\.021448678406842826\ \(0\)\
\-\ vascular\\:\\ 0\\.020912852757849546\ \(0\)\
\-\ no\\:\\ 0\\.02060218124384153\ \(0\)\
\-\ while\\:\\ 0\\.020472393659900463\ \(0\)\
\-\ any\\:\\ 0\\.020472393659900463\ \(0\)\
\-\ 20\\:\\ 0\\.02043621655542585\ \(0\)\
\-\ artery\\:\\ 0\\.019673699598628414\ \(0\)\
\-\ primary\\:\\ 0\\.019478109127157892\ \(0\)\
\-\ wall\\:\\ 0\\.0192696548337631\ \(0\)\
\-\ on\\:\\ 0\\.01913416386483804\ \(0\)\
\-\ likely\\:\\ 0\\.018929558822687566\ \(0\)\
\-\ all\\:\\ 0\\.018856729373604098\ \(0\)\
\-\ two\\:\\ 0\\.018811691284908418\ \(0\)\
\-\ shows\\:\\ 0\\.018591822269646213\ \(0\)\
\-\ cyst\\:\\ 0\\.018273454094687964\ \(0\)\
\-\ due\\:\\ 0\\.01820869340859116\ \(0\)\
\-\ one\\:\\ 0\\.018136729128512313\ \(0\)\
\-\ common\\:\\ 0\\.01796464542992162\ \(0\)\
\-\ these\\:\\ 0\\.017888154332160115\ \(0\)\
\-\ prior\\:\\ 0\\.017723493145048085\ \(0\)\
\-\ both\\:\\ 0\\.01766480656559731\ \(0\)\
\-\ more\\:\\ 0\\.017394214186218285\ \(0\)\
\-\ associated\\:\\ 0\\.016696301401979592\ \(0\)\
\-\ posterior\\:\\ 0\\.016380594098089077\ \(0\)\
\-\ were\\:\\ 0\\.016328721906627073\ \(0\)\
\-\ had\\:\\ 0\\.015782784990421742\ \(0\)\
\-\ but\\:\\ 0\\.01566446387173116\ \(0\)\
\-\ after\\:\\ 0\\.015367167233915013\ \(0\)\
\-\ female\\:\\ 0\\.01528574807791675\ \(0\)\
\-\ within\\:\\ 0\\.01458957780587778\ \(0\)\
\-\ normal\\:\\ 0\\.01293362053329489\ \(0\)\
\-\ as\\:\\ 0\\.01272588713664168\ \(0\)\
\-\ there\\:\\ 0\\.012604290929020212\ \(0\)\
\-\ not\\:\\ 0\\.012505436150768084\ \(0\)\
\-\ an\\:\\ 0\\.012113285084809366\ \(0\)\
\-\ history\\:\\ 0\\.012102554326114377\ \(0\)\
\-\ are\\:\\ 0\\.012020086634342368\ \(0\)\
\-\ old\\:\\ 0\\.00937520041938838\ \(0\)\
